Implanon: Subdermal single rod contraceptive implant

40Citations
Citations of this article
118Readers
Mendeley users who have this article in their library.

Abstract

Objectives: Study was conducted to determine acceptability, efficacy, safety, return of fertility with Implanon. Methods: Volunteers having regular menstruation, requiring spacing formed study population. Implanon was inserted within 5 days of LMP or concurrent with MTP. Woman was asked to record bleeding pattern, side effects. Implanon duration was 3 years but Implanon was removed before, if patient wanted pregnancy/for side effects. Subjects who did not adopt family planning method after removal were followed up for return of ovulation and pregnancy. Results: 200 subjects were enrolled (160 within 5 days of LMP, 40 concurrent with MTP). 74 implanon removals were done. (16 after tenure completion, 58 for other reasons.) 16% cases discontinued implanon for polymenorrhagia, 10% for irregular bleeding, 4.5% for amenorrhea. There was no failure of implanon. 40% had return of ovulation within one month, 95.8% conceived within 12 months. Conclusions: Implanon is safe, effective, well accepted method of contraception. © 2011 Federation of Obstetric & Gynecological Societies of India.

Author supplied keywords

Cite

CITATION STYLE

APA

Bhatia, P., Nangia, S., Aggarwal, S., & Tewari, C. (2011). Implanon: Subdermal single rod contraceptive implant. Journal of Obstetrics and Gynecology of India, 61(4), 422–425. https://doi.org/10.1007/s13224-011-0066-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free